| Population toxicokinetic modeling of cadmium for health risk assessment B Amzal, B Julin, M Vahter, A Wolk, G Johanson, A Åkesson Environmental health perspectives 117 (8), 1293-1301, 2009 | 216 | 2009 |
| Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation HA Barton, WA Chiu, R Woodrow Setzer, ME Andersen, AJ Bailer, ... Toxicological Sciences 99 (2), 395-402, 2007 | 155 | 2007 |
| Experimental exposure to methyltertiary-butyl ether A Nihlén, R Wålinder, A Löf, G Johanson Toxicology and applied pharmacology 148 (2), 281-287, 1998 | 154 | 1998 |
| Toxicity review of ethylene glycol monomethyl ether and its acetate ester G Johanson Critical reviews in toxicology 30 (3), 307-345, 2000 | 139 | 2000 |
| Percutaneous absorption of 2-butoxyethanol vapour in human subjects. G Johanson, A Boman Occupational and Environmental Medicine 48 (11), 788-792, 1991 | 127 | 1991 |
| Toxicokinetics of inhaled 2-butoxyethanol (ethylene glycol monobutyl ether) in man G Johanson, H Kronborg, PH Näslund, MB Nordqvist Scandinavian journal of work, environment & health, 594-602, 1986 | 102 | 1986 |
| The absorption, blood levels, and excretion of mercury after a single dose of mercury vapor in humans G Sandborgh-Englund, CG Elinder, G Johanson, B Lind, I Skare, ... Toxicology and applied pharmacology 150 (1), 146-153, 1998 | 100 | 1998 |
| Modelling of respiratory exchange of polar solvents G Johanson The Annals of occupational hygiene 35 (3), 323-339, 1991 | 97 | 1991 |
| Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles U Carlander, D Li, O Jolliet, C Emond, G Johanson International journal of nanomedicine, 625-640, 2016 | 96 | 2016 |
| The global landscape of occupational exposure limits—Implementation of harmonization principles to guide limit selection M Deveau, CP Chen, G Johanson, D Krewski, A Maier, KJ Niven, ... Journal of occupational and environmental hygiene 12 (sup1), S127-S144, 2015 | 90 | 2015 |
| Toxicokinetics and acute effects of MTBE and ETBE in male volunteers G Johanson, A Nihlén, A Löf Toxicology letters 82, 713-718, 1995 | 88 | 1995 |
| Acute effects of exposure to vapours of acetic acid in humans L Ernstgård, A Iregren, B Sjögren, G Johanson Toxicology letters 165 (1), 22-30, 2006 | 87 | 2006 |
| A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation G Johanson, JG Filser Archives of toxicology 67 (3), 151-163, 1993 | 87 | 1993 |
| Acute respiratory effects of exposure to ammonia on healthy persons BM Sundblad, BM Larsson, F Acevedo, L Ernstgård, G Johanson, ... Scandinavian journal of work, environment & health, 313-321, 2004 | 85 | 2004 |
| Toxicokinetics of organic solvents: a review of modifying factors A Löf, G Johanson Critical reviews in toxicology 28 (6), 571-650, 1998 | 82 | 1998 |
| Toxicokinetics of Perfluorinated Alkyl Acids Influences Their Toxic Potency in the Zebrafish Embryo (Danio rerio) C Vogs, G Johanson, M Näslund, S Wulff, M Sjödin, M Hellstrandh, ... Environmental science & technology 53 (7), 3898-3907, 2019 | 81 | 2019 |
| Liquid/air partition coefficients of six commonly used glycol ethers. G Johanson, B Dynesius Occupational and Environmental Medicine 45 (8), 561-564, 1988 | 80 | 1988 |
| Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation G Johanson, JG Filser Archives of toxicology 66 (4), 291-295, 1992 | 76 | 1992 |
| Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats D Li, G Johanson, C Emond, U Carlander, M Philbert, O Jolliet Nanotoxicology 8 (sup1), 128-137, 2014 | 75 | 2014 |
| Acute effects of a fungal volatile compound R Wålinder, L Ernstgård, G Johanson, D Norbäck, P Venge, G Wieslander Environmental health perspectives 113 (12), 1775-1778, 2005 | 73 | 2005 |
Linda SchenkInstitute of Environmental Medicine, Karolinska InstitutetVerified email at ki.se
